Cargando…
Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
The objective of this study was to determine associations of paraoxonase-1 (PON-1) with development of cancer therapy–related cardiac dysfunction (CTRCD). PON-1 is a cardioprotective enzyme associated with high-density lipoprotein that prevents oxidized low-density lipoprotein formation. Given the r...
Autores principales: | Thompson, Elizabeth W., Demissei, Biniyam G., Smith, Amanda M., Brahmbhatt, Priya, Wang, Jessica, Clark, Amy, DeMichele, Angela, Narayan, Vivek, Shah, Payal, Sun, Lova, Lefebvre, Benedicte, Fradley, Michael G., Carver, Joseph R., Tang, W.H. Wilson, Ky, Bonnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807731/ https://www.ncbi.nlm.nih.gov/pubmed/35128203 http://dx.doi.org/10.1016/j.jacbts.2021.10.010 |
Ejemplares similares
-
Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
por: Demissei, Biniyam G., et al.
Publicado: (2020) -
Longitudinal Right Ventricular Systolic Function Changes in Breast Cancer Patients Treated With Cardiotoxic Cancer Therapy
por: Demissei, Biniyam G., et al.
Publicado: (2022) -
BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors
por: Demissei, Biniyam G., et al.
Publicado: (2022) -
Sustained Increases in IGFBP-7 May Be Related to Doxorubicin in Breast Cancer Patients
por: Wilcox, Nicholas S., et al.
Publicado: (2021) -
Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
por: Fradley, Michael G., et al.
Publicado: (2023)